Research News
Catch up on the latest news from across the ataxia research world right here.
If you are interested in taking part in research, please click here for current opportunities. If you would like to find out about the research we are currently funding, please click here.
For other enquiries, or if you can’t find information on the type of ataxia you have, please contact our Helpline by emailing help@ataxia.org.uk or calling 0800 995 6037 (opening hours Monday-Thursday 10.30am-2.30pm).
MHRA approves Omav
Sign up to a dedicated newsletter and receive the latest news about Biogen's Omaveloxolone (Skyclarys) treatment for adults with Friedreich’s ataxia.
New study published on goal-directed Rehabilitation vs. Standard Care in those with hereditary Cerebellar ataxia
Cerebellar ataxia, Friedreich's ataxia, Research News, SCAs, spastic ataxias, AOA2, ARSACS, ataxia research, CANVAS, cerebellar ataxia, FA, Friedreich's ataxia, Progressive Ataxias, Rehabilitation, SCA, Spastic Ataxia, SPG70PTC Therapeutics announces positive updates from their phase III trial of Vatiquinone in FA
Friedreich's ataxia, Friedreich's ataxia pharma news, Research News, Friedreich's ataxia, Friedreich's ataxia news, Friedreich's ataxia pharma, Friedreich's ataxia pharma news, Friedreich's ataxia research, PTC Therapeutics, vatiquinone0Subscribe To Our Newsletter
Let's stay in touch
Subscribe to our monthly eNews
Sign up in seconds & stay up to date with all things ataxia with the monthly eNewsletter
Newsletter Signup June 2022
Or, join Ataxia UK for FREE
Become a friend of Ataxia UK today and as well as the monthly eNewsletter, access the best support, keep up to date with the latest ataxia research news, and receive the ataxia magazine – all for FREE